Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #12,301 to #12,350.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Assault by exposure to or harmful effects of vitamin D or derivatives (Q100509)
  2. Assault by exposure to or harmful effects of electrolytic, caloric or water-balance agents (Q100508)
  3. Assault by exposure to or harmful effects of drugs affecting uric acid metabolism (Q100507)
  4. Assault by exposure to or harmful effects of mineralocorticoids (Q100506)
  5. Assault by exposure to or harmful effects of stimulant laxatives (Q100505)
  6. Assault by exposure to or harmful effects of bisphosphonates (Q100504)
  7. Assault by exposure to or harmful effects of histamine H2-receptor blockers (Q100503)
  8. Assault by exposure to or harmful effects of acidifying or alkalising agents (Q100502)
  9. Assault by exposure to or harmful effects of natural blood or blood products (Q100501)
  10. Assault by exposure to or harmful effects of mineral salts, not elsewhere classified (Q100500)
  11. Assault by exposure to or harmful effects of mineralocorticoids antagonists (Q100499)
  12. Assault by exposure to or harmful effects of other diuretics (Q100498)
  13. Assault by exposure to or harmful effects of anticoagulants (Q100497)
  14. Assault by exposure to or harmful effects of carbonic-anhydrase inhibitors (Q100496)
  15. Assault by exposure to or harmful effects of anticoagulant antagonists, vitamin K or other coagulants (Q100495)
  16. Assault by exposure to or harmful effects of other primarily systemic agents, not elsewhere classified (Q100494)
  17. Assault by exposure to or harmful effects of diphenhydramine (Q100493)
  18. Assault by exposure to or harmful effects of enzymes (Q100492)
  19. Assault by exposure to or harmful effects of antivaricose drugs, including sclerosing agents (Q100491)
  20. Assault by exposure to or harmful effects of antineoplastic antimetabolites (Q100490)
  21. Assault by exposure to or harmful effects of other antihypertensive drugs (Q100489)
  22. Assault by exposure to or harmful effects of other H1-receptor antagonists (Q100488)
  23. Assault by exposure to or harmful effects of other antineoplastic drugs (Q100487)
  24. Assault by exposure to or harmful effects of antihyperlipidemic or antiarteriosclerotic drugs (Q100486)
  25. Assault by exposure to or harmful effects of immunosuppressive agents (Q100485)
  26. Assault by exposure to or harmful effects of peripheral vasodilators (Q100484)
  27. Assault by exposure to or harmful effects of angiotensin-converting-enzyme inhibitors (Q100483)
  28. Assault by exposure to or harmful effects of nitroglycerin, nitroglycerol, medicinal (Q100482)
  29. Assault by exposure to or harmful effects of antineoplastic natural products (Q100481)
  30. Assault by exposure to or harmful effects of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations (Q100480)
  31. Assault by exposure to or harmful effects of other coronary vasodilators (Q100479)
  32. Assault by exposure to or harmful effects of antiallergic or antiemetic drugs (Q100478)
  33. Assault by exposure to or harmful effects of salbutamol (Q100477)
  34. Assault by exposure to or harmful effects of antifungal antibiotics, systemically used (Q100476)
  35. Assault by exposure to or harmful effects of expectorants (Q100475)
  36. Assault by exposure to or harmful effects of anthelminthics (Q100474)
  37. Assault by exposure to or harmful effects of aminophylline, theophylline (Q100473)
  38. Assault by exposure to or harmful effects of antiviral drugs (Q100472)
  39. Assault by exposure to or harmful effects of skeletal muscle relaxants (Q100471)
  40. Assault by exposure to or harmful effects of antitussives (Q100470)
  41. Assault by exposure to or harmful effects of cardiac-stimulant glycosides or drugs of similar action (Q100469)
  42. Assault by exposure to or harmful effects of terbutaline (Q100468)
  43. Assault by exposure to or harmful effects of rifampicin (Q100467)
  44. Assault by exposure to or harmful effects of aminoglycosides (Q100466)
  45. Assault by exposure to or harmful effects of unspecified drugs acting on muscles (Q100465)
  46. Assault by exposure to or harmful effects of tetracyclines (Q100464)
  47. Assault by exposure to or harmful effects of chloramphenicol group (Q100463)
  48. Assault by exposure to or harmful effects of other anti-common-cold drugs (Q100462)
  49. Assault by exposure to or harmful effects of antiasthmatics, not elsewhere classified (Q100461)
  50. Assault by exposure to or harmful effects of oxytocic drugs (Q100460)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://determinar.ia.br/wiki/Special:ItemsWithoutSitelinks"